Blueprint Medicines Corp (BPMC): Biotechnology Value Fund Reports 10.4% Stake

According to a recent 13G filing with the US Securities and Exchange Commission, Mark Lampert‘s Biotechnology Value Fund L. P. owns 2.84 million...

Keep Reading →